However, the low numbers of circulating CD4+CD25high as well as CD8+CD25high in patients before treatment was a surprising finding and in contrast to earlier reports (Liyanage et al, 2002), showing an increased proportion of CD4+/CD25+ cells in breast and pancreatic cancer patients. This evidence concerns the gene CD8A and familial pancreatic carcinoma.